XpresSpa Signs Contract with JFK International Air Terminal LLC for COVID-19 Screening and Testing Location
May 22 2020 - 9:00AM
XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”),
a health and wellness company, today provided a business update
related to its objective of pursuing COVID-19 screening and testing
in convenient and accessible locations at U.S. airports.
The Company is pleased to announce that it has
signed a contract with JFK International Air Terminal LLC
(“JFKIAT”) to pilot test its concept of providing diagnostic
COVID-19 tests located in Terminal 4. To facilitate the JFK pilot
test, the Company has signed an agreement with JFKIAT for a new
modular constructed testing facility within the terminal. The site
will host nine separate testing rooms with a capacity to administer
over 500 tests per day. The Company intends to offer its services
to airline employees, contractors and workers, concessionaires and
their employees, TSA officers, and U.S. Customs and Border
Protection agents.
All COVID-19 screening and testing will be
conducted by a newly launched brand, XpresCheck™, which will
operate under the Company’s XpresTest® subsidiary.
The Company is also working closely with the
Port Authority of New York and New Jersey to bring XpresCheck
locations to other locations. A formal announcement with additional
details is expected to be made in the coming weeks in conjunction
with the Port Authority of New York and New Jersey and JFKIAT.
In addition, the Company is in discussions with
other U.S. airports regarding the temporary conversions of existing
XpresSpa locations into XpresCheck testing sites as it looks to
roll out this concept further.
The Company also announced the launch of
XpresCheck, the operating brand under which the Company’s
previously formed XpresTest subsidiary will screen and test for
COVID-19. Although the JFK pilot test site will be in a newly
constructed modular facility, the Company is discussing temporary
conversions of existing XpresSpa locations into XpresCheck testing
sites as it looks to roll out this concept to other U.S.
airports.
Doug Satzman, XpresSpa CEO, stated, "We are
thrilled to be in a position to launch our first pilot test at JFK
Terminal 4 and are hopeful that this will serve as a model in other
U.S. airports. The vision and close collaboration with JFKIAT
senior leaders have enabled this initiative to move quickly so that
we can together support the safety and health of front line airport
workers and travelers as New York’s recovery plan takes form.”
About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a health
and wellness holding company. XpresSpa Group’s core asset,
XpresSpa, is a leading airport retailer of spa services and related
health and wellness products, with 51 locations in 25 airports
globally. XpresSpa offers services that are tailored specifically
to the busy travel customer. XpresSpa is committed to providing
exceptional customer experiences with its innovative premium spa
services, as well as luxury travel products and accessories.
XpresSpa provides almost one million services to customers per year
at its locations in the United States, Netherlands, and the United
Arab Emirates. To learn more about XpresSpa Group, visit
www.XpresSpaGroup.com. To learn more about XpresSpa, visit
www.XpresSpa.com.
Forward-Looking StatementsThis
press release may contain "forward-looking" statements within the
meaning of Section 27A of the Securities Act of 1933, and Section
21E of the Securities Exchange Act of 1934. These include
statements preceded by, followed by or that otherwise include the
words "believes," "expects," "anticipates," "estimates,"
"projects," "intends," "should," "seeks," "future," "continue," or
the negative of such terms, or other comparable terminology.
Forward-looking statements relating to expectations about future
results or events are based upon information available to XpresSpa
Group as of today's date and are not guarantees of the future
performance of the company, and actual results may vary materially
from the results and expectations discussed. Additional information
concerning these and other risks is contained in XpresSpa Group’s
most recently filed Annual Report on Form 10-K, Quarterly Report on
Form 10-Q, recent Current Reports on Form 8-K and other Securities
and Exchange Commission filings. All subsequent written and oral
forward-looking statements concerning XpresSpa Group, or other
matters and attributable to XpresSpa Group or any person acting on
its behalf are expressly qualified in their entirety by the
cautionary statements above. XpresSpa Group does not undertake any
obligation to publicly update any of these forward-looking
statements to reflect events or circumstances that may arise after
the date hereof.
Investor Relations:ICRRaphael
Gross(203) 682-8253
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Mar 2024 to Apr 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Apr 2023 to Apr 2024